NP_000423.2
[Other Products]
NCBI GenBank Nucleotide #
|
[Other Products]
UniProt Primary Accession #
|
[Other Products]
UniProt Related Accession #
NCBI Official Full Name
myosin regulatory light chain 2, ventricular/cardiac muscle isoform
NCBI Official Synonym Full Names
myosin light chain 2
NCBI Protein Information
myosin regulatory light chain 2, ventricular/cardiac muscle isoform
UniProt Protein Name
Myosin regulatory light chain 2, ventricular/cardiac muscle isoform
UniProt Synonym Gene Names
UniProt Entry Name
MLRV_HUMAN
NCBI Summary for MYL2
Thus gene encodes the regulatory light chain associated with cardiac myosin beta (or slow) heavy chain. Ca+ triggers the phosphorylation of regulatory light chain that in turn triggers contraction. Mutations in this gene are associated with mid-left ventricular chamber type hypertrophic cardiomyopathy. [provided by RefSeq, Jul 2008]
UniProt Comments for MYL2
MRLC2V: myosin regulatory light chain 2, ventricular/cardiac muscle isoform. Ca+ triggers the phosphorylation of regulatory light chain that in turn triggers contraction. Mutations in MYL2 are associated with mid-left ventricular chamber type hypertrophic cardiomyopathy.
Protein type: Contractile
Chromosomal Location of Human Ortholog: 12q24.11
Cellular Component: sarcomere; cytoskeleton; myofibril; myosin complex; cytosol; A band; actin cytoskeleton
Molecular Function: actin monomer binding; protein binding; structural constituent of muscle; calcium ion binding; myosin heavy chain binding
Biological Process: muscle cell fate specification; heart contraction; regulation of striated muscle contraction; ventricular cardiac muscle morphogenesis; cardiac myofibril assembly; negative regulation of cell growth; muscle fiber development; post-embryonic development; muscle filament sliding; cardiac muscle contraction
Disease: Cardiomyopathy, Familial Hypertrophic, 10
Research Articles on MYL2
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Products associated with anti-MYL2 antibody
Pathways associated with anti-MYL2 antibody
Diseases associated with anti-MYL2 antibody
Disease Name |
Pubmed Publications |
Cardiovascular Diseases Antibodies |
>35 publications with MYL2 and Cardiovascular Diseases |
Heart Diseases Antibodies |
>33 publications with MYL2 and Heart Diseases |
Cardiomyopathy, Hypertrophic Antibodies |
>27 publications with MYL2 and Cardiomyopathy, Hypertrophic |
Cardiomyopathy, Hypertrophic, Familial Antibodies |
>11 publications with MYL2 and Cardiomyopathy, Hypertrophic, Familial |
Hypertrophy Antibodies |
>10 publications with MYL2 and Hypertrophy |
Hypertension Antibodies |
>5 publications with MYL2 and Hypertension |
Cardiomegaly Antibodies |
>5 publications with MYL2 and Cardiomegaly |
Neoplasms Antibodies |
>5 publications with MYL2 and Neoplasms |
Cardiomyopathy, Familial Hypertrophic, 10 Antibodies |
>4 publications with MYL2 and Cardiomyopathy, Familial Hypertrophic, 10 |
Inflammation Antibodies |
>2 publications with MYL2 and Inflammation |
Organs/Tissues associated with anti-MYL2 antibody
|